2023 Q1 Form 10-Q Financial Statement

#000149315223003538 Filed on February 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q3 2022 Q2
Revenue $25.00K
YoY Change 25.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $307.1K $286.8K
YoY Change 4.25% -94.52%
Operating Profit -$307.1K -$261.8K
YoY Change 6.05% -94.97%
Interest Expense $377.0K $303.1K
YoY Change -523.61% -683.62%
% of Operating Profit
Other Income/Expense, Net -$1.472M -$1.559M
YoY Change -12.08% 123.06%
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$1.779M -$1.821M
YoY Change -13.33% -69.45%
Net Earnings / Revenue -7284.05%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 33.65B shares 30.35B shares
Diluted Shares Outstanding 34.02B shares 30.35B shares

Balance Sheet

Concept 2023 Q1 2022 Q3 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $39.42K $13.93K $67.90K
Short-Term Investments
Other Short-Term Assets $242.4K $541.8K $365.4K
YoY Change 4.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $282.3K $556.3K $433.8K
YoY Change -93.5% -80.89% -9.77%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $37.60K $34.25K $36.16K
YoY Change -96.03% -94.76% -91.91%
TOTAL ASSETS
Total Short-Term Assets $282.3K $556.3K $433.8K
Total Long-Term Assets $37.60K $34.25K $36.16K
Total Assets $319.9K $590.5K $470.0K
YoY Change -93.96% -83.43% -49.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $615.4K $611.5K $615.8K
YoY Change 13.89% 3.65% 1.2%
Accrued Expenses $1.262M $1.050M $931.4K
YoY Change 48.46% 6.7% -53.28%
Deferred Revenue $760.4K $660.4K $665.4K
YoY Change 14.29%
Short-Term Debt $814.3K $641.4K
YoY Change -42.96% -52.13%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $8.606M $6.858M $7.013M
YoY Change 37.94% 12.81% 1.27%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $8.606M $6.858M $7.013M
Total Long-Term Liabilities
Total Liabilities $8.606M $6.858M $7.013M
YoY Change 37.94% 12.81% 1.27%
SHAREHOLDERS EQUITY
Retained Earnings -$75.93M -$73.54M -$71.72M
YoY Change
Common Stock $70.29M $67.91M $65.82M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $44.17K $44.17K $44.17K
YoY Change
Treasury Stock Shares 484.8K shares 484.8K shares
Shareholders Equity -$8.287M -$6.268M -$6.544M
YoY Change
Total Liabilities & Shareholders Equity $319.9K $590.5K $470.0K
YoY Change -93.96% -83.43% -49.35%

Cashflow Statement

Concept 2023 Q1 2022 Q3 2022 Q2
OPERATING ACTIVITIES
Net Income -$1.779M -$1.821M
YoY Change -13.33% -69.45%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$407.2K
YoY Change 0.12%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $16.00K
YoY Change 6.67%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $353.3K
YoY Change -50.08%
NET CHANGE
Cash From Operating Activities -$407.2K
Cash From Investing Activities
Cash From Financing Activities $353.3K
Net Change In Cash -$53.97K
YoY Change -157.78%
FREE CASH FLOW
Cash From Operating Activities -$407.2K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 dei Entity Central Index Key
EntityCentralIndexKey
0000704172
CY2022Q3 dei Amendment Flag
AmendmentFlag
false
CY2022Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2022Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q2 PHIL Common Stock To Be Issued
CommonStockToBeIssued
usd
CY2021Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
usd
CY2021Q3 PHIL Increase Decrease In Incoming Transfer In Progress
IncreaseDecreaseInIncomingTransferInProgress
usd
CY2021Q3 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
usd
CY2021Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
usd
CY2021Q3 PHIL Increase Decrease In Subfund Obligations
IncreaseDecreaseInSubfundObligations
usd
CY2021Q3 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2021Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
usd
CY2022Q3 dei Document Type
DocumentType
10-Q
CY2022Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q3 dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
CY2022Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q3 dei Entity File Number
EntityFileNumber
001-38255-NY
CY2022Q3 dei Entity Registrant Name
EntityRegistrantName
PHI GROUP, INC
CY2022Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
WY
CY2022Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-0114535
CY2022Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
2323 Main Street
CY2022Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
CY2022Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2022Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92614
CY2022Q3 dei City Area Code
CityAreaCode
714
CY2022Q3 dei Local Phone Number
LocalPhoneNumber
793-9227
CY2022Q3 dei Security12b Title
Security12bTitle
Common Stock
CY2022Q3 dei Trading Symbol
TradingSymbol
PHIL
CY2022Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2022Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2022Q3 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q3 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q3 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
33645885430 shares
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13926 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67896 usd
CY2022Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
546 usd
CY2022Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
546 usd
CY2022Q3 us-gaap Other Assets Current
OtherAssetsCurrent
541825 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
365360 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
556297 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
433802 usd
CY2022Q3 us-gaap Long Term Investments
LongTermInvestments
34250 usd
CY2022Q2 us-gaap Long Term Investments
LongTermInvestments
36161 usd
CY2022Q3 us-gaap Assets
Assets
590547 usd
CY2022Q2 us-gaap Assets
Assets
469963 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
611455 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
615805 usd
CY2022Q3 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
1586619 usd
CY2022Q2 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
1574775 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1049685 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
931417 usd
CY2022Q3 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
922229 usd
CY2022Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
676888 usd
CY2022Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
889500 usd
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
756250 usd
CY2022Q3 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
1035886 usd
CY2022Q2 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
1077218 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
660434 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
665434 usd
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
102368 usd
CY2022Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
715677 usd
CY2022Q3 us-gaap Liabilities
Liabilities
6858175 usd
CY2022Q2 us-gaap Liabilities
Liabilities
7013465 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
2440 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
2440 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33645885430 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33645885430 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31429380453 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31429380453 shares
CY2022Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 1,500 reverse split
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
33645885 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
31429381 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
34261391 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
34394912 usd
CY2022Q3 PHIL Common Stock To Be Issued
CommonStockToBeIssued
16000 usd
CY2022Q3 PHIL Common Stock To Be Cancelled
CommonStockToBeCancelled
35500 usd
CY2022Q2 PHIL Common Stock To Be Cancelled
CommonStockToBeCancelled
35500 usd
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
484767 shares
CY2022Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
484767 shares
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
44170 usd
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
44170 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73538986 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-71717973 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-574688 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-572591 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-6267628 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-6543502 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
590547 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
469963 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25000 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20000 usd
CY2022Q3 us-gaap Salaries And Wages
SalariesAndWages
90000 usd
CY2021Q3 us-gaap Salaries And Wages
SalariesAndWages
90000 usd
CY2022Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
183915 usd
CY2021Q3 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
132583 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12889 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5006646 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
286804 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
5229229 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-261804 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5209229 usd
CY2022Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
370 usd
CY2021Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
223 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
303133 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
51944 usd
CY2022Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
1256446 usd
CY2021Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
699220 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1559209 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-750941 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1821013 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-5960170 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30349670198 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26934105454 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30349670198 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26934105454 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1821013 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-5960170 usd
CY2022Q3 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
186 usd
CY2022Q3 PHIL Net Change Due To Conversion Of Notes
NetChangeDueToConversionOfNotes
-2082983 usd
CY2021Q3 PHIL Net Change Due To Conversion Of Notes
NetChangeDueToConversionOfNotes
-5478306 usd
CY2022Q3 PHIL Increase Decrease In Incoming Transfer In Progress
IncreaseDecreaseInIncomingTransferInProgress
-9500 usd
CY2022Q3 us-gaap Increase Decrease In Deferred Charges
IncreaseDecreaseInDeferredCharges
185965 usd
CY2022Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
176465 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4350 usd
CY2021Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-18618 usd
CY2022Q3 PHIL Increase Decrease In Subfund Obligations
IncreaseDecreaseInSubfundObligations
11844 usd
CY2022Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
118268 usd
CY2021Q3 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
103750 usd
CY2022Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5000 usd
CY2021Q3 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-10000 usd
CY2022Q3 us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-613309 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-492547 usd
CY2021Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
75132 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-407228 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-406732 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-207583 usd
CY2022Q3 PHIL Proceeds From Financing Loans
ProceedsFromFinancingLoans
41332 usd
CY2021Q3 PHIL Proceeds From Financing Loans
ProceedsFromFinancingLoans
101204 usd
CY2022Q3 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
378590 usd
CY2021Q3 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
793909 usd
CY2022Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
16000 usd
CY2021Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
353258 usd
CY2021Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
707705 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-53970 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
93390 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
67896 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
95344 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13926 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
188734 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-5997389 usd
CY2021Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
1537 usd
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
599019 usd
CY2021Q3 PHIL Stock Issued During Period Value Accrued Salaries
StockIssuedDuringPeriodValueAccruedSalaries
1585490 usd
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
4908800 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-5960170 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-2514670 usd
CY2021Q4 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
2660911 usd
CY2021Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
9734200 usd
CY2021Q4 PHIL Stock Issued During Period Value Accrued Salaries
StockIssuedDuringPeriodValueAccruedSalaries
297721 usd
CY2021Q4 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
172609 usd
CY2021Q4 PHIL Stock Issued During Value Exercise Of Warrants
StockIssuedDuringValueExerciseOfWarrants
219654 usd
CY2021Q4 PHIL Stock Issued During Period Value Previously Paid Subscription
StockIssuedDuringPeriodValuePreviouslyPaidSubscription
165000 usd
CY2021Q4 PHIL Stock Issued During Period Preferred Shares Issued For Loan Repayment
StockIssuedDuringPeriodPreferredSharesIssuedForLoanRepayment
600 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-10591638 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-1463100 usd
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
1870240 usd
CY2022Q1 PHIL Stock Issued During Value Exercise Of Warrants
StockIssuedDuringValueExerciseOfWarrants
676604 usd
CY2022Q1 PHIL Stock Issued During Period Value Accrued Salaries
StockIssuedDuringPeriodValueAccruedSalaries
143000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-946420 usd
CY2022Q2 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
904787 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
5000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-6543502 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-6543502 usd
CY2022Q3 PHIL Stock Issued During Value Conversions Of Promissory Notes
StockIssuedDuringValueConversionsOfPromissoryNotes
233614 usd
CY2022Q3 PHIL Stock Issued During Value Exercise Of Warrants
StockIssuedDuringValueExerciseOfWarrants
2395080 usd
CY2022Q3 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
545710 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-6267628 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-6267628 usd
CY2022Q3 us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_805_eus-gaap--NatureOfOperations_zDBlQxdjaUIc" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">NOTE 1</span></b> – <b><span id="xdx_823_znjlKYmFGWbd">NATURE OF BUSINESS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INTRODUCTION</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PHI Group, Inc. (n/k/a Philux Global Group Inc) (the “Company” or “PHI”) (<span style="text-decoration: underline">www.philuxglobal.com</span>) is primarily engaged in mergers and acquisitions, advancing PHILUX Global Funds, SCA, SICAV-RAIF, a “Reserved Alternative Investment Fund” (“RAIF”) under the laws of Luxembourg, and establishing the Asia Diamond Exchange in Vietnam. Besides, the Company provides corporate finance services, including merger and acquisition advisory and consulting services for client companies through our wholly owned subsidiary PHILUX Capital Advisors, Inc. (formerly PHI Capital Holdings, Inc.) (www.philuxcapital.com<span style="text-decoration: underline">)</span> and invests in selective industries and special situations aiming to potentially create significant long-term value for our shareholders. PHILUX Global Funds intends to include a number of sub-funds for investment in select growth opportunities in the areas of agriculture, renewable energy, real estate, infrastructure, and the Asia Diamond Exchange in Vietnam.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BACKGROUND</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Originally incorporated on June 8, 1982 as JR Consulting, Inc., a Nevada corporation, the Company applied for a Certificate of Domestication and filed Articles of Domestication to become a Wyoming corporation on September 20, 2017. In the beginning, the Company was foremost engaged in mergers and acquisitions and had an operating subsidiary, Diva Entertainment, Inc., which operated two modeling agencies, one in New York and one in California. In January 2000, the Company changed its name to Providential Securities, Inc., a Nevada corporation, following a business combination with Providential Securities, Inc., a California-based financial services company. In February 2000, the Company then changed its name to Providential Holdings, Inc. In October 2000, Providential Securities withdrew its securities brokerage membership and ceased its financial services business. Subsequently, in April 2009, the Company changed its name to PHI Group, Inc. From October 2000 to October 2011, the Company and its subsidiaries were engaged in various transactions in connection with mergers and acquisitions advisory and consulting services, real estate and hospitality development, mining, oil and gas, telecommunications, technology, healthcare, private equity, and special situations. In October 2011, the Company discontinued the operations of Providential Vietnam Ltd., Philand Ranch Limited, a United Kingdom corporation (together with its subsidiaries Philand Ranch - Singapore, Philand Corporation - US, and Philand Vietnam Ltd. - Vietnam), PHI Gold Corporation (formerly PHI Mining Corporation, a Nevada corporation), and PHI Energy Corporation (a Nevada corporation), and mainly focused on acquisition and development opportunities in energy and natural resource businesses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is currently focused on PHILUX Global Funds, SCA, SICAV-RAIF by launching Philux Global Select Growth Fund and potentially other sub-funds for investment in real estate, renewable energy, infrastructure, agriculture and healthcare and the Asia Diamond Exchange in Vietnam. In addition, PHILUX Capital Advisors, Inc. (formerly Capital Holdings, Inc.), a wholly owned subsidiary of the Company, continues to provide corporate and project finance services, including merger and acquisition (M&amp;A) advisory and consulting services for U.S. and international companies. The Company has signed agreements to acquire majority equity interests in Kota Construction LLC and Kota Energy Group LLC which are engaged in solar energy business (<span style="text-decoration: underline">https://www.kotasolar.com</span>), Tin Thanh Group, a Vietnamese joint stock company (<span style="text-decoration: underline">www.tinthanhgroup.vn</span>) and Van Phat Dat Joint Stock Company, a Vietnamese joint stock company. In addition, the Company is in the process of amending the Purchase and Sale Agreement that was originally signed on January 18, 2022 with Five-Grain Treasure Spirits Co., Ltd., a Chinese baiju distiller, to collaborate in launching American-made baiju products through Empire Spirits, Inc., a subsidiary of the Company. The Company will relocate CO2-1-0 (CARBON) Corp., a subsidiary of the Company engaged in carbon emission mitigation using blockchain and crypto technologies, to the United Arab Emirates. These activities are disclosed in greater detail elsewhere in this report. No assurances can be made that the Company will be successful in achieving its plans.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BUSINESS STRATEGY</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">PHI’s strategy is to:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. Identify, build, acquire, commit and deploy valuable resources with distinctive competitive advantages;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. Identify, evaluate, acquire, participate and compete in attractive businesses that have large, growing market potential;</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. Build an attractive investment that includes points of exit for investors through capital appreciation or spin-offs of business units.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2022Q3 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_zKE3AXAUd6nb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>USE OF ESTIMATES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
546 usd
CY2022Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
546 usd
CY2022Q3 us-gaap Long Term Investments
LongTermInvestments
34250 usd
CY2022Q3 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zvfFaqitzull" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>RISKS AND UNCERTAINTIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the normal course of business, the Company is subject to certain risks and uncertainties. The Company provides its service and receives marketable securities upon execution of transactions. Consequently, the value of the securities received from customers can be affected by economic fluctuations and each customer’s business growth. The actual realized value of these securities could be significantly different than recorded value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
546 usd
CY2022Q2 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
546 usd
CY2022Q2 us-gaap Long Term Investments
LongTermInvestments
36161 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
611455 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
615805 usd
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
608521 usd
CY2022Q3 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
1586619 usd
CY2022Q2 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
1574775 usd
CY2021Q2 us-gaap Settlement Liabilities Current
SettlementLiabilitiesCurrent
1474775 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1049685 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
931417 usd
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1993478 usd
CY2022Q3 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
922229 usd
CY2022Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
676888 usd
CY2021Q2 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
325621 usd
CY2022Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
889500 usd
CY2022Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
756250 usd
CY2021Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
220230 usd
CY2022Q3 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
1035886 usd
CY2022Q2 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
1077218 usd
CY2021Q2 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
1720323 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
660434 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
665434 usd
CY2021Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
582237 usd
CY2022Q3 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
102368 usd
CY2022Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
715677 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6858175 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
7013465 usd
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6925185 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1049685 usd
CY2022Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
763842 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
285843 usd
CY2022Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
641380 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
660434 usd
CY2022Q3 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
1035886 usd
CY2022Q2 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
1077218 usd
CY2022Q3 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
1035886 usd
CY2022Q2 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
1077218 usd
CY2022Q3 us-gaap Accrued Payroll Taxes Current And Noncurrent
AccruedPayrollTaxesCurrentAndNoncurrent
5747 usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
484767 shares
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
44170 usd
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
33645885430 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33645885430 shares
CY2015Q1 us-gaap Employee Stock Ownership Plan Esop Number Of Allocated Shares
EmployeeStockOwnershipPlanESOPNumberOfAllocatedShares
1000000 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0118 pure
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.393 pure
CY2022Q2 PHIL Annual Revenues
AnnualRevenues
5500000000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-73538986 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-6267628 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1821013 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-5960170 usd

Files In Submission

Name View Source Status
0001493152-23-003538-index-headers.html Edgar Link pending
0001493152-23-003538-index.html Edgar Link pending
0001493152-23-003538.txt Edgar Link pending
0001493152-23-003538-xbrl.zip Edgar Link pending
ex21-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
phil-20220930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
phil-20220930_cal.xml Edgar Link unprocessable
phil-20220930_pre.xml Edgar Link unprocessable
phil-20220930_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
phil-20220930_def.xml Edgar Link unprocessable